o2h Discovery is a multi-award-winning integrated drug discovery provider, blending the best of East and West. Headquartered in Cambridge, UK and with 750+ personnel at their research center in Ahmedabad, India, o2h Discovery’s large team of experts delivers high-quality services, covering chemistry, biology, DMPK, scale-up/PR&D; supporting organizations of all sizes with cost-effective solutions from target validation all the way to IND-enabling studies.
For over 2 decades, o2h Group (Ventures, Discovery, Tech) has pioneered drug discovery & technology services, invested in and incubated life science companies, and brought scientific communities together. This multi-dimensional approach means o2h is trusted by clients from around the world, with a reputation for innovation, cutting-edge facilities, specialist expertise, and excellent communication.
MassBio Member Spotlight: o2h Discovery, part of o2h Group
Locations:
- USA: CIC, One Broadway, Cambridge, MA, 02142, United States
- UK: Mill Scitech Park, Hauxton House, Cambridge, CB22 5HX, UK,
- India: Shirish Research Centre, Ahmedabad, Gujarat, 382213, India
Website: o2hdiscovery.co
Leadership:
- Sunil Shah | CEO, o2h Ventures and Co-Founder, o2h discovery
- Prashant Shah | CEO, o2h discovery and Co-Founder, o2h group
Business Type:
- Integrated Drug Discovery Service Provider (CRO)
- Most therapeutic areas and target classes; multi-modality capabilities
- Pre-Clinical Drug Discovery (Chemistry, Biology, DMPK, ADL, scale-up/PR&D)
